WrapMail, Inc. changes name and symbol to Canbiola, Inc. (OTC-CANB), entering Cannabidiol (CBD) and Medical Cannabis Industry
HICKSVILLE, NY - (NewMediaWire) - May 16, 2017 - Canbiola, Inc. (
The company maintains its technological products, Wrapmail and Prosperity/Bullseye, and will work to integrate these products into the sales and distribution process for the company's CBD products.
Mr. Marco Alfonsi, CEO of Canbiola, stated, "It was a clear choice to enter the fast growing CBD and medical cannabis industry; however, after reviewing many initial transactions in this space, the company decided it was in the best interest of our shareholders to launch independently and seek to grow both organically and through potential future acquisitions." He added, "I'm extraordinarily excited about this new venture, and it's with great determination and a renewed vigor we embark down this path."
About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states.
The company also owns two technological solutions, Wrapmail (US Patent 8,572,275), which turns traditional email into a powerful marketing and branding tool, as well Prosperity Systems and the Bullseye platform of document management and compliance targeted at broker dealers, public companies, and governmental agencies providing a flawless all-in-one solution for document management, retention and compliance.
Forward looking statements and risks and uncertainties
Matters discussed in this press release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price. For more complete information regarding our business at Canbiola.
CONTACT INFORMATION
-
Canbiola Investor Relations
IR@canbiola.com
Phone (516) 595-9544
http://www.canbiola.com